← CRS Congressional Research Service reports
All Eyes on Allergan: Drug Company’s Unprecedented Move Raises Questions for Patent and Drug Law (Part II)
LSB · Legal Sidebar · 2017-10-12 · LSB10010
Report
- CRS ID
LSB10010- Series
- Legal Sidebar
- Publication date
- 2017-10-12
Documents
- PDF
- https://www.everycrsreport.com/files/2017-10-12_LSB10010_19938baab152f257d82a592a68c47f5dd1a8df7e.pdf
- HTML
- https://www.everycrsreport.com/files/2017-10-12_LSB10010_19938baab152f257d82a592a68c47f5dd1a8df7e.html
- Source
- EveryCRSReport.com
- Machine
- JSON-LD · Markdown